Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse

Not Applicable

Completed

• Conditions: Posttraumatic Stress Disorder; Substance Abuse

• Registration Number: NCT00656344
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

This study is exploring the use of an intervention designed to treat PTSD in individuals with comorbid PTSD and substance abuse resulting from the attacks of September 11 or from military service in Iraq. A cognitive behavioral treatment protocol will be used to treat PTSD. The exposure component of the protocol will be enhanced with the use of virtual reality in which the client will view a virtual environment while describing their trauma.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-10
• Study First Submitted: 2008-04-07
• Study First Submitted QC: 2008-04-07
• Study First Posted: 2008-04-11
• Status Verified: 2013-12
• Primary Completion: 2013-12
• Study Completion: 2013-12
• Last Update Submitted: 2013-12-06
• Last Update Posted: 2013-12-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 3

Inclusion Criteria

• English-speaking
• Between the ages of 18 and 70
• Exposed to the WTC Attacks (were in towers or in the immediate area) or veterans of the Iraq War
• Diagnosed with PTSD symptoms
• Current substance abuse disorder or history of substance abuse disorder

Exclusion Criteria

• Presence of current organic mental disorder
• Presence or history of schizophrenia, bipolar disorder or depression with psychotic features, delusional disorder
• Active suicidal ideation, intent, or plan
• Active homicidal ideation, intent, or plan
• Use of pacemaker
• Medically unstable
• History of seizures

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
posttraumatic stress symptomatology	prior to treatment, during the treatment, immediately following treatment and 6 months after the completion of treatment

Secondary Outcome Measures

Name	Time	Method
substance use symptomatology	prior to treatment, during treatment, immediately following treatment, and 6 months after the completion of treatment

Trial Locations

Locations (1)

Weill Cornell Medical College; 🇺🇸 New York, New York, United States